In an era of rapid disruption, static data is no longer enough. We bridge the gap between complex market data and actionable strategy through our unique RaaS (Research-as-a-Service) framework. Explore our latest Industry Intelligence Briefings, methodology deep-dives, and expert analysis designed to provide the clarity you need for high-stakes board presentations, acquisition due diligence, and long-term strategic planning. Need specific answers? Commission a bespoke intelligence study tailored to your requirements.
Blue Owl down 66%, Blackstone injecting $400M to meet BCRED redemptions, the Fed launching its first private credit monitoring survey. Here …
Veolia bought out CDPQ's stake in its Water Technologies segment for EUR 1.5 billion. Here is what that signals about a $303.8 billion marke…
Why a tablet made in Hyderabad might be exported to Lagos while an identical one stays in Mumbai -- and why sizing India's pharmaceutical in…
Real, verified FY2026 rankings of India's top pharma companies by both revenue and manufacturing/export scale -- two genuinely different lis…
Perlite and vermiculite market estimates vary by 4x across published reports because no public company anchors the sizing. We cross-checked …
ADCs are growing at 18% CAGR inside an oncology market averaging 11% overall — and Keytruda's patent cliff hits just as that wave reaches fu…
Drug Product Formulation and Fill-Finish, not API peptide synthesis, is the single largest stage of the GLP-1 manufacturing value chain — an…
Eli Lilly's market cap crossed $1 trillion in August 2026 - the first healthcare company ever to do so. Inside the $1.65T global pharmaceuti…
Global GLP-1 manufacturing capacity is racing from $45 billion to a projected $180 billion by 2031. The real capacity bottleneck - and the r…
Oral semaglutide is already commercial. A five-company pipeline of dual-agonist and biosimilar challengers is advancing behind it. Inside th…
Why a single tablet might involve chemistry in China, formulation in India, and consumption in the United States — and why market sizing the…
How verification research replaced a proposed key player with a company few fleet managers have heard of, revealing the real structural faul…
